Akbar K. Waljee
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
474
Citations
14,891
Est. group size
~28
Recurring co-author estimate
Active years
22
Publishing since 2005
Typically publishes in teams of ~5 · 29% small-team papers (≤3 authors) · across 20 venues
- Validity and reliability of the Swahili version of the 25-item Revised Child Anxiety and Depression Scale in Kenya
OSF Preprints (OSF Preprints) · 2026
- Pan-cancer molecular signatures connecting aspartate transaminase to cancer prognosis, metabolic and immune signatures
Frontiers in Oncology · 2026
- Healthcare providers’ perspectives on the clinical utility of artificial intelligence in pregnancy care: a mixed methods study in Kilifi, Kenya (Preprint)
2026
- EP65: OUTCOMES OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON MAINTENANCE INFLIXIMAB: A NATIONAL COHORT STUDY
Gastroenterology · 2025
- Using machine learning algorithms to optimize treatment with high-cost biologics in a national cohort of patients with inflammatory bowel disease
JAMIA Open · 2025
- Leveraging data science and machine learning for urban climate adaptation in two major African cities: a HE<sup>2</sup>AT Center study protocol
BMJ Open · 2024
- Health Data Sciences and Cardiovascular Disease in Africa: Needs and the Way Forward
Current Atherosclerosis Reports · 2024
- Efficacy and Safety of Sphingosine 1-Phosphate Receptor Modulators for Ulcerative Colitis
Journal of Clinical Gastroenterology · 2024
- P708 Multiple Biosimilar Infliximab Switching is Not Associated with Adverse Outcomes in Inflammatory Bowel Disease: A Real-World Effectiveness Analysis in a National U.S. Cohort
Journal of Crohn s and Colitis · 2024
- MULTIPLE BIOSIMILAR INFLIXIMAB SWITCHING IS NOT ASSOCIATED WITH DISEASE FLARE IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EFFECTIVENESS ANALYSES IN A NATIONAL U.S. COHORT
Inflammatory Bowel Diseases · 2024
- MULTIPLE BIOSIMILAR INFLIXIMAB SWITCHING IS NOT ASSOCIATED WITH DISEASE FLARE IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EFFECTIVENESS ANALYSES IN A NATIONAL U.S. COHORT
Gastroenterology · 2024
- Sa1746 MULTIPLE BIOSIMILAR INFLIXIMAB SWITCHING IS NOT ASSOCIATED WITH ADVERSE OUTCOMES IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EFFECTIVENESS ANALYSES IN A NATIONAL U.S. COHORT
Gastroenterology · 2024
- PATTERNS OF STEROID USE AMONG A REAL-WORLD NATIONAL COHORT OF VETERANS WITH INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases · 2023
- Pharmacogenetic testing and monitoring of complete blood counts among Veterans newly prescribed thiopurine treatments: a retrospective cohort study
Journal of Pharmaceutical Policy and Practice · 2023
- P750 Biosimilar Infliximab Switching is Not Associated with Adverse Outcomes: A Real-World Effectiveness Analyses in a National U.S. Cohort of U.S. Military Veterans with Inflammatory Bowel Disease
Journal of Crohn s and Colitis · 2023
- Gastroenterology×113
- The American Journal of Gastroenterology×25
- Inflammatory Bowel Diseases×25
- Clinical Gastroenterology and Hepatology×24
- Journal of Crohn s and Colitis×10
- Ryan W. Stidham
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Ryan Stidham
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Shrinivas Bishu
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Calen A. Steiner
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Jessica L. Sheehan
Biochemistry, Genetics and Molecular Biology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile